Legal Representation
Attorney
Danny M. Awdeh
USPTO Deadlines
Next Deadline
95 days remaining
NOA E-Mailed - SOU Required
Due Date
April 29, 2026
Extension Available
Until October 29, 2026
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 30, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 29, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 29, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 29, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 29, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 5, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 16, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 16, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 16, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 3, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Dec 3, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Sep 3, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 3, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 3, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 3, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 7, 2024 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 7, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 8, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of genetic diseases and disorders
Class 042
Research and development of pharmaceuticals for the treatment of genetic diseases and disorders; medical and scientific research services in the field of genetic disease and disorder treatment
Class 044
Providing medical and health information in the field of genetic diseases and disorders; providing information in the field of genetic diseases and disorders treatment for medical purposes; Providing links to the web sites of others featuring medical and health information about genetic diseases and disorders; providing links to the web sites of others featuring information about the diagnosis and treatment of genetic diseases and disorder
Additional Information
Design Mark
The mark consists of the stacked and stylized wording "ROCKET PHARMA" to the left of a cluster of five hexagons where the top four are completely shaded and the bottom fifth is only a line drawing.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ROCKET PHARMACEUTICALS
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"